ARCHIVES

Sharfstein To Leave FDA

This article is from The Cancer Letter archive.

Vol. 37 No. 01 | January 7, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008

Greenberg: More Work Needs to be Done

November 7, 2014

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

April 20, 2012

Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths

June 24, 1994

Funding opportunities listed.

June 25, 2004

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

November 4, 1988